EMEA-001113-PIP01-10-M05

Key facts

Invented name
Deltyba
Active substance
Delamanid
Therapeutic area
Infectious diseases
Decision number
P/0269/2016
PIP number
EMEA-001113-PIP01-10-M05
Pharmaceutical form(s)
  • Film-coated tablet
  • Dispersible tablet for oral suspension
Condition(s) / indication(s)
Treatment of multi-drug-resistant tuberculosis
Route(s) of administration
Oral use
Contact for public enquiries
Otsuka Europe Development and Commercialisation Ltd.
Germany
Tel. +49 6995 5044321
Fax +49 6995 504450
E-mail: paediatric-info@otsuka.de
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating